Myasthenia Gravis (MG)

Myasthenia gravis is an autoimmune disease where the immune system attacks the body’s own tissues, interrupting the connection between nerves and muscles.

Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults with Generalized Myasthenia Gravis (gMG)

By Sujatha Gurunathan | March 9, 2023
Blog Post

MDA Announces Advocacy Collaboration Grants Recipients

By Mark Fisher | February 16, 2023
Headshot of Aimee Zehner, a white woman with curly, light brown hair wearing cat-eye, rhinestone-tipped glasses.
Blog Post

Navigating the Long Journey to a Rare Disease Diagnosis

By Shaila Wunderlich | January 18, 2023
Blog Post

2022 Highlights – The Year of Independence

By Donald S. Wood, Ph.D., President and CEO, Muscular Dystrophy Association | December 9, 2022
Alt Text Illustration of a woman holding a magnifying glass in front of a computer screen with beakers, a microscope, and DNA double helix, suggesting a web search for research content.
Featured Article

3 Steps to Find Reliable Information on Neuromuscular Disease Research

By Amy Bernstein | November 18, 2022
Green background reads Clinical Trial Alert with a semi circle image of a scientist's hand and beakers
Blog Post

Clinical Trial Alert: Phase 3 Study of Inebilizumab in Adults with Myasthenia Gravis

By Sujatha Gurunathan | October 24, 2022
A dark blue background with a light blue image of the DNA double helix
Blog Post

2023 MDA Clinical & Scientific Conference

By Sharon Hesterlee, Ph.D. | September 23, 2022
Female Scientist Looking Under Microscope with test tubes on her table
Blog Post

Muscular Dystrophy Association Announces 70 Research Grants Totaling Over $17 Million

By MDA Staff | September 19, 2022
Anastasia Corp stands with her hands on her hips in a maroon cheerleading uniform.
Featured Article

After-School Activities for All

By Donna Albrecht | August 23, 2022
Blog Post

Simply Stated: What is Myasthenia Gravis (MG)?

By Sujatha Gurunathan | June 27, 2022